{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:03:04Z","timestamp":1779915784889,"version":"3.53.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jsps.2023.101849","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T02:51:21Z","timestamp":1699066281000},"page":"101849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Preparation and characterization of vaginal suppository of semisynthetic derivatives of ergot alkaloids cabergoline"],"prefix":"10.1007","volume":"31","author":[{"given":"Pouria","family":"Rahmanian-Devin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Fadaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mashreghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid Reza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2023.101849_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105602","article-title":"Vaginal suppositories of cumin seeds essential oil for treatment of vaginal candidiasis: Formulation, in vitro, in vivo, and clinical evaluation","volume":"157","author":"Abd Ellah","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2023.101849_b0010","series-title":"Seminars in Reproductive Medicine","article-title":"Treatment of ovarian hyperstimulation syndrome","author":"Aboulghar","year":"2010"},{"issue":"5","key":"10.1016\/j.jsps.2023.101849_b0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1773-2247(06)50070-X","article-title":"Formulation and stability of rofecoxib suppositories","volume":"16","author":"Abou-Taleb","year":"2006","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"12","key":"10.1016\/j.jsps.2023.101849_b0020","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1093\/humrep\/dem315","article-title":"Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study","volume":"22","author":"Alvarez","year":"2007","journal-title":"Hum. Reprod."},{"issue":"8","key":"10.1016\/j.jsps.2023.101849_b0025","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2007-0409","article-title":"Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction","volume":"92","author":"\u00c1lvarez","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.jsps.2023.101849_b0030","first-page":"48","article-title":"Cabergoline for reducing ovarian hyperstimulation syndrome in assisted reproductive technology treatment cycles. A prospective randomized controlled trial","volume":"60","author":"Amir","year":"2015","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.jsps.2023.101849_b0035","doi-asserted-by":"crossref","unstructured":"Ata, B., A. Seyhan, S. Orhaner, and B. Urman, High dose cabergoline in management of ovarian hyperstimulation syndrome. Fertility and sterility, 2009. 92(3): p. 1168. e1-1168. e4.","DOI":"10.1016\/j.fertnstert.2009.05.021"},{"issue":"1","key":"10.1016\/j.jsps.2023.101849_b0040","first-page":"54","article-title":"Is cabergoline a better drug to inhibit lactation in patients with psychotic symptoms?","volume":"27","author":"Baeza Pertegaz","year":"2002","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jsps.2023.101849_b0045","unstructured":"Baviskar, P., S. Jaiswal, S. Sadique, and A. Landged, Formulation and evaluation of lornoxicam suppositories. The Pharma Innovation, 2013. 2(7, Part A): p. 20."},{"issue":"8","key":"10.1016\/j.jsps.2023.101849_b0050","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1039\/C8OB02856G","article-title":"The roles of Lewis acidic additives in organotransition metal catalysis","volume":"17","author":"Becica","year":"2019","journal-title":"Org. Biomol. Chem."},{"issue":"4","key":"10.1016\/j.jsps.2023.101849_b0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","article-title":"BDDCS applied to over 900 drugs","volume":"13","author":"Benet","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.jsps.2023.101849_b0060","doi-asserted-by":"crossref","unstructured":"bharathi Balakrishnan, S., G.B. Veerakanellore, and T. Stalin, In-vitro dissolution rate and molecular docking studies of cabergoline drug with \u03b2-cyclodextrin. Journal of molecular structure, 2018. 1160: p. 1-8.","DOI":"10.1016\/j.molstruc.2018.01.054"},{"issue":"6","key":"10.1016\/j.jsps.2023.101849_b0065","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1472-6483(10)60401-4","article-title":"Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study","volume":"17","author":"Carizza","year":"2008","journal-title":"Reprod. Biomed. Online"},{"issue":"1","key":"10.1016\/j.jsps.2023.101849_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tjog.2011.01.014","article-title":"Update on management of ovarian hyperstimulation syndrome","volume":"50","author":"Chen","year":"2011","journal-title":"Taiwanese J. Obstet. Gynecol."},{"key":"10.1016\/j.jsps.2023.101849_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105141","article-title":"Development of doxycycline hyclate suppositories and pharmacokinetic study in rabbits","volume":"142","author":"Christ","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jsps.2023.101849_b0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14656566.1.3.555","article-title":"Cabergoline","volume":"1","author":"Colao","year":"2000","journal-title":"Expert Opin. Pharmacother."},{"issue":"7","key":"10.1016\/j.jsps.2023.101849_b0085","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1210\/en.2004-1445","article-title":"Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice","volume":"146","author":"Cristina","year":"2005","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.jsps.2023.101849_b0090","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharma."},{"key":"10.1016\/j.jsps.2023.101849_b0095","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00003088-200342070-00003","article-title":"Clinical pharmacokinetics of cabergoline","volume":"42","author":"Del Dotto","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.jsps.2023.101849_b0100","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/OGX.0b013e3181e09621","article-title":"Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review","volume":"65","author":"Donders","year":"2010","journal-title":"Obstet. Gynecol. Survey"},{"issue":"2","key":"10.1016\/j.jsps.2023.101849_b0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1507\/endocrj.42.153","article-title":"In vivo effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors","volume":"42","author":"Eguchi","year":"1995","journal-title":"Endocr. J."},{"key":"10.1016\/j.jsps.2023.101849_b0110","unstructured":"ABOU FAZELI, R., et al., Fonnulation, preparation and physico-chemical control of vaginal suppositories containing volatile oils of allium sativum and zataria multiflora. 2000."},{"key":"10.1016\/j.jsps.2023.101849_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-015-0102-4","article-title":"Dopamine agonist inhibits vascular endothelial growth factor protein production and secretion in granulosa cells","volume":"13","author":"Ferrero","year":"2015","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"10.1016\/j.jsps.2023.101849_b0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12958-015-0102-4","article-title":"Dopamine agonist inhibits vascular endothelial growth factor protein production and secretion in granulosa cells","volume":"13","author":"Ferrero","year":"2015","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"8","key":"10.1016\/j.jsps.2023.101849_b0125","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.5958\/0974-360X.2017.00479.6","article-title":"Screening of suppository bases for rectal delivery of carbamazepine","volume":"10","author":"Havaldar","year":"2017","journal-title":"Res. J. Pharm. Technol."},{"issue":"2","key":"10.1016\/j.jsps.2023.101849_b0130","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3109\/10717544.2014.928760","article-title":"Advanced topical drug delivery system for the management of vaginal candidiasis","volume":"23","author":"Johal","year":"2016","journal-title":"Drug Deliv."},{"issue":"1\u20132","key":"10.1016\/j.jsps.2023.101849_b0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpharm.2012.11.040","article-title":"Pharmaceutical development and optimization of azithromycin suppository for paediatric use","volume":"441","author":"Kauss","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"04","key":"10.1016\/j.jsps.2023.101849_b0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/2231-0770.165121","article-title":"Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoingin vitro fertilization\/intracytoplasmic sperm injection treatment cycles: a randomized controlled study","volume":"5","author":"Kilic","year":"2015","journal-title":"Avicenna J. Med."},{"issue":"4","key":"10.1016\/j.jsps.2023.101849_b0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/2231-0770.165121","article-title":"Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment cycles: a randomized controlled study","volume":"5","author":"K\u0131l\u0131\u00e7","year":"2015","journal-title":"Avicenna J. Med."},{"issue":"5","key":"10.1016\/j.jsps.2023.101849_b0150","first-page":"585","article-title":"Preparation and characterisation of fluconazole vaginal films for the treatment of vaginal candidiasis","volume":"75","author":"Kumar","year":"2013","journal-title":"Indian J. Pharm. Sci."},{"issue":"862","key":"10.1016\/j.jsps.2023.101849_b0155","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/pgmj.73.862.507","article-title":"Effects of cabergoline in a pituitary adenoma secreting follicle-stimulating hormone","volume":"73","author":"Leese","year":"1997","journal-title":"Postgrad. Med. J."},{"issue":"3","key":"10.1016\/j.jsps.2023.101849_b0160","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.fertnstert.2013.11.005","article-title":"Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials","volume":"101","author":"Leitao","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsps.2023.101849_b0165","doi-asserted-by":"crossref","unstructured":"Mancini, T., F.F. Casanueva, and A. Giustina, Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am, 2008. 37(1): p. 67-99, viii.","DOI":"10.1016\/j.ecl.2007.10.013"},{"issue":"9","key":"10.1016\/j.jsps.2023.101849_b0170","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1248\/bpb.19.1210","article-title":"Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats","volume":"19","author":"Miyagi","year":"1996","journal-title":"Biol. Pharm. Bull."},{"issue":"11","key":"10.1016\/j.jsps.2023.101849_b0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10856-018-6174-x","article-title":"Electrospinning of zein\/propolis nanofibers; antimicrobial properties and morphology investigation","volume":"29","author":"Moradkhannejhad","year":"2018","journal-title":"J. Mater. Sci. - Mater. Med."},{"issue":"2","key":"10.1016\/j.jsps.2023.101849_b0180","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0015-0282(16)58113-8","article-title":"Vaginal cabergoline in the treatment of hyperprolactinemic patients intolerant to oral dopaminergics","volume":"65","author":"Motta","year":"1996","journal-title":"Fertil. Steril."},{"issue":"67.87","key":"10.1016\/j.jsps.2023.101849_b0185","first-page":"19.0","article-title":"Amorphous solid dispersions in early stage of formulation development: predicting excipient influence on dissolution profiles using DDDPlus","volume":"586","author":"Njoku","year":"2020","journal-title":"Cellul."},{"issue":"11","key":"10.1016\/j.jsps.2023.101849_b0190","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/humrep\/16.11.2263","article-title":"Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome","volume":"16","author":"Papaleo","year":"2001","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.jsps.2023.101849_b0195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2005.07.1292","article-title":"Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles","volume":"85","author":"Papanikolaou","year":"2006","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jsps.2023.101849_b0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14227\/DT180311P55","article-title":"Studies in dissolution enhancement of ezetimibe by solid dispersions in combination with a surface adsorbent","volume":"8","author":"Parmar","year":"2011","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.jsps.2023.101849_b0205","doi-asserted-by":"crossref","unstructured":"Perkampus, H.H., LJ Bellamy: The Infrared Spectra of Complex Molecules, Vol. 1, 3. Auflage, Chapman and Hall Ltd., London 1975, 433 Seiten, 32 Abb., 22 Tabellen, Preis:\u00a3 8.\u2014. 1976, Wiley Online Library.","DOI":"10.1002\/bbpc.19760800121"},{"issue":"1","key":"10.1016\/j.jsps.2023.101849_b0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","article-title":"The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery","volume":"94","author":"Pivonello","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jsps.2023.101849_b0215","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4103\/0250-474X.44602","article-title":"Formulation development and release studies of indomethacin suppositories","volume":"70","author":"Sah","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.jsps.2023.101849_b0220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0002-9459(24)07817-3","article-title":"Ergot and its alkaloids","volume":"70","author":"Schiff","year":"2006","journal-title":"Am. J. Pharm. Educ."},{"issue":"4","key":"10.1016\/j.jsps.2023.101849_b0225","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1208\/s12249-009-9329-8","article-title":"Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies","volume":"10","author":"Sharma","year":"2009","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.jsps.2023.101849_b0230","doi-asserted-by":"crossref","first-page":"644","DOI":"10.5530\/ijper.52.4.75","article-title":"Design, synthesis and evaluation of 4-Aminopyridine analogues as Cholinesterase inhibitors for management of Alzheimer\u2019s diseases","volume":"52","author":"Singh","year":"2018","journal-title":"Indian J. Pharm. Educ."},{"issue":"18","key":"10.1016\/j.jsps.2023.101849_b0235","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1242\/jcs.053124","article-title":"Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2","volume":"122","author":"Sinha","year":"2009","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.jsps.2023.101849_b0240","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/humupd\/dmn008","article-title":"Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome","volume":"14","author":"Soares","year":"2008","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jsps.2023.101849_b0245","series-title":"Clinical gynecologic endocrinology and infertility","author":"Speroff","year":"2005"},{"issue":"04","key":"10.1016\/j.jsps.2023.101849_b0250","article-title":"Design of curcumin suppositories for effective treatment of vaginal candidiasis using cow ghee as a suppository base","volume":"11","author":"Sudke","year":"2017","journal-title":"Asian J. Pharma. (AJP)"},{"key":"10.1016\/j.jsps.2023.101849_b0255","unstructured":"Sweetman, S.C., Martindale: the complete drug reference. 2005."},{"key":"10.1016\/j.jsps.2023.101849_b0260","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008605.pub2","article-title":"Cabergoline for preventing ovarian hyperstimulation syndrome","volume":"2","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.jsps.2023.101849_b0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/ph9010013","article-title":"Potential use of antimicrobial peptides as vaginal spermicides\/microbicides","volume":"9","author":"Tanphaichitr","year":"2016","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.jsps.2023.101849_b0270","first-page":"12","article-title":"\u201c There they go again\u201d\u2013hCG and weight loss","volume":"107","author":"Toffle","year":"2011","journal-title":"W. V. Med. J."},{"key":"10.1016\/j.jsps.2023.101849_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.102873","article-title":"Hesperetin loaded proposomal gel for topical antioxidant activity","volume":"66","author":"Vaz","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423003444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423003444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:29:11Z","timestamp":1736184551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016423003444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1319016423003444"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101849","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and characterization of vaginal suppository of semisynthetic derivatives of ergot alkaloids cabergoline","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"101849"}}